Single Agent Polysaccharopeptide Delays Metastases and Improves Survival in Naturally Occurring Hemangiosarcoma
Figure 1
Days to progression of abdominal metastases for 15 dogs diagnosed with splenic hemangiosarcoma randomized to one of three doses of I’m-Yunity (5 dogs in each dose group). * Denotes a statistically significant difference () in median days to progression of abdominal metastases between groups (30 versus 112 days).
